Comparison and recommendation of dietary patterns based on nutrients for Eastern and Western patients with inflammatory bowel disease
While still highly effective, it falls short of the results seen with tirzepatide
Certain health conditions that cause or exacerbate bone loss may be asymptomatic and require laboratory testing for detection
Lancet Diabetes Endocrinol 12:380389 Svendstrup M, Rasmussen AK, Kistorp C et al (2024) Semaglutide treatment of hypothalamic obesity - a real-life data study
Semaglutide GLP-1 belongs to a category of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists, often referred to as incretin mimetics. By imitating the function of GLP-1, a natural hormone in our bodies, Semaglutide GLP-1 plays an important role in controlling blood sugar levels, reducing appetite, and slowing down gastric emptying all of which can contribute to weight loss
Bile acids profiles were analyzed on an Acquity UPLC system coupled to a Waters Xevo TQ-S MS (Waters, Manchester, UK), equipped with a C18 reverse-phase column with 1.7 mm particle size (Waters Corp., Milford, MA, USA)